SELLAS Life Sciences Group, Inc. - Common Stock (SLS)

CUSIP: 81642T209

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
178,475,456
Total 13F shares
32,917,301
Share change
+6,137,446
Total reported value
$53,012,951
Put/Call ratio
2%
Price per share
$1.61
Number of holders
92
Value change
+$9,796,863
Number of buys
49
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 81642T209?
CUSIP 81642T209 identifies SLS - SELLAS Life Sciences Group, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SLS - SELLAS Life Sciences Group, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
3.7%
6,654,799
$14,574,010 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
2.6%
4,590,273
$10,052,697 30 Jun 2025
13F
MARSHALL WACE, LLP
13F
Company
1.5%
2,715,489
$5,946,922 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
2,200,428
$4,819,427 30 Jun 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.83%
1,489,672
$3,262,382 30 Jun 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.63%
1,127,225
$2,468,623 30 Jun 2025
13F
STATE STREET CORP
13F
Company
0.62%
1,112,705
$2,436,824 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.61%
1,084,478
$2,375,007 30 Jun 2025
13F
Nuveen, LLC
13F
Company
0.54%
971,329
$2,127,211 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.39%
698,493
$1,529,700 30 Jun 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.26%
465,506
$1,019,458 30 Jun 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.24%
426,584
$934,000 30 Jun 2025
13F
Barbara A. Wood
3/4/5
EVP, Gen. Counsel, Corp. Sec.
mixed-class rows
249,450
mixed-class rows
$821,565 22 Jan 2024
UBS Group AG
13F
Company
0.17%
309,687
$678,214 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.16%
294,106
$644,092 30 Jun 2025
13F
Anson Funds Management LP
13F
Company
0.15%
275,000
$602,250 30 Jun 2025
13F
Opus Capital Group, LLC
13F
Company
0.13%
240,000
$526,000 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.11%
201,460
$441,198 30 Jun 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.11%
197,642
$432,836 30 Jun 2025
13F
BARCLAYS PLC
13F
Company
0.1%
172,803
$378,439 30 Jun 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.08%
135,789
$297,374 30 Jun 2025
13F
Robert Francomano
3/4/5
Chief Commercial Officer
mixed-class rows
91,836
mixed-class rows
$278,365 22 Jan 2024
CITADEL ADVISORS LLC
13F
Company
0.05%
84,993
$186,135 30 Jun 2025
13F
XTX Topco Ltd
13F
Company
0.04%
76,900
$168,411 30 Jun 2025
13F
LPL Financial LLC
13F
Company
0.04%
67,560
$147,956 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.03%
61,892
$135,543 30 Jun 2025
13F
MetLife Investment Management, LLC
13F
Company
0.03%
58,844
$128,868 30 Jun 2025
13F
Atom Investors LP
13F
Company
0.03%
54,624
$119,627 30 Jun 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.03%
53,815
$117,855 30 Jun 2025
13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
13F
Company
0.03%
52,210
$114,340 30 Jun 2025
13F
Mariner, LLC
13F
Company
0.03%
51,109
$111,929 30 Jun 2025
13F
Invesco Ltd.
13F
Company
0.03%
50,166
$109,863 30 Jun 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.03%
49,960
$109,412 30 Jun 2025
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.03%
49,300
$107,967 30 Jun 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.03%
47,959
$106,000 30 Jun 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.03%
46,682
$102,234 30 Jun 2025
13F
INTECH INVESTMENT MANAGEMENT LLC
13F
Company
0.03%
46,217
$101,215 30 Jun 2025
13F
CITIGROUP INC
13F
Company
0.02%
42,415
$92,889 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
34,579
$75,728 30 Jun 2025
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.02%
34,551
$75,667 30 Jun 2025
13F
Cubist Systematic Strategies, LLC
13F
Company
0.02%
31,314
$68,578 30 Jun 2025
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.02%
27,503
$60,232 30 Jun 2025
13F
Quadrature Capital Ltd
13F
Company
0.01%
24,284
$52,696 30 Jun 2025
13F
Police & Firemen's Retirement System of New Jersey
13F
Company
0.01%
23,351
$51,139 30 Jun 2025
13F
INDEPENDENT FINANCIAL GROUP, LLC
13F
Company
0.01%
23,250
$50,918 30 Jun 2025
13F
SG Americas Securities, LLC
13F
Company
0.01%
20,910
$46,000 30 Jun 2025
13F
GREAT VALLEY ADVISOR GROUP, INC.
13F
Company
0.01%
20,000
$44,000 30 Jun 2025
13F
SIMON QUICK ADVISORS, LLC
13F
Company
0.01%
20,000
$43,800 30 Jun 2025
13F
ProShare Advisors LLC
13F
Company
0.01%
19,571
$42,860 30 Jun 2025
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.01%
19,248
$42,000 30 Jun 2025
13F

Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock (SLS) as of Q3 2025

As of 30 Sep 2025, SELLAS Life Sciences Group, Inc. - Common Stock (SLS) was held by 92 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,917,301 shares. The largest 10 holders included VANGUARD GROUP INC, Anson Funds Management LP, BlackRock, Inc., MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MORGAN STANLEY, Nuveen, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and NORTHERN TRUST CORP. This page lists 93 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
78
Q3 2025 holders
92
Holder diff
14
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .